NBP2001 / SK Bio - LARVOL DELTA

Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19) (clinicaltrials.gov) - P1 | N=50 | Completed | Sponsor: SK Bioscience Co., Ltd. | Active, not recruiting ➔ Completed

Trial completion • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases • IL4

Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19) (clinicaltrials.gov) - P1; N=50; Active, not recruiting; Sponsor: SK Bioscience Co., Ltd.

Clinical • New P1 trial • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases • IL4

"@OakRidgeOffice @ORCID_Org @SenateDems @SenateGOP @realDonaldTrump @BarackObama @GSK_bio @LibraryOfMed Meet your mourder, he es the one who contributed to your little gift COVID-19" (@ditz_erick)

Infectious Disease • Novel Coronavirus Disease

"#COVID19vaccine #TrumpOwnsEveryDeath @funder @TomPerez @SpeakerPelosi @JoeBiden @RepSwalwell @SenKamalaHarris @SenSchumer @GOP @CDCgov @US_FDA @InovioPharma @GSK_bio @USMerckProducts @Merck @pfizer" (@KathyGrants)

Infectious Disease • Novel Coronavirus Disease

"@pfizer @sanofipasteur @GSK_bio A P50M reward for covid19 vaccine. @WHO @CDCgov" (@JudeAbarquez)

Infectious Disease • Novel Coronavirus Disease

"Collaboration has never been so meaningful to fight #COVID19 @SanofiFR @GSK_bio" (@IGrosmaitre)

Infectious Disease • Novel Coronavirus Disease

"Special guest Jim Brase of @Livermore_Lab details how #supercomputing is battling #COVID19 - full podcast at https://t.co/kTGbclblaR @UCSF @GSK_bio @theNCI #HPC #COVIDー19" (@ThisWeekinHPC)

"Well done @GSK_bio #Worthing stepping up to tackle #COVID19Pandemic #bbcqt #COVIDー19 #clapforkeyworkers @MattHancock" (@CoolTownCrier)

SK Bioscience starts animal trial of COVID-19 vaccine (Korea Biomedical Review) - "SK Bioscience said that it has succeeded in discovering a vaccine candidate for COVID-19 and started the animal clinical trial of the candidate substance."

Clinical